Healthcare -
Biotechnology - NASDAQ - US
$ 8.32
2.4 %
$ 316 M
Market Cap
14.0
P/E
TRDA - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss TRDA - Entrada Therapeutics, Inc.
-43 K
LAST VALUE
85.54%
2 YEAR CAGR
73.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR